LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery? version 1.5 (discovery.lifemapsc.com). LifeMap Discovery? is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology, disease mechanisms and etiology.
LifeMap Discovery? is a key component in LifeMap's integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards?, the leading human gene database and MalaCards, the human disease database . LifeMap Sciences holds the exclusive worldwide license to market GeneCards? and MalaCards from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.